Osisko Intersects 80 Metres Averaging 1.93% Cu at Gaspé

MONTREAL, June 09, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") ( TSX: OM ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is pleased to announce initial results from the 2026 drill program at the Gaspé Copper Project, located in the Gaspé Peninsula of Eastern Québec. Five drills are currently active on the property, with two additional drills commencing work this month.

GlobeNewsWire • Jun 9, 2026

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights.   We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

PRNewsWire • Jun 5, 2026

Osisko Metals Files NI 43-101 Technical Report for the Gaspé Copper Project

TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX: OM; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce the filing on SEDAR+ of a technical report titled "NI 43-101 Technical Report on the Gaspé Copper Project with an Updated Mineral Resource Estimate for the Copper Mountain Deposit, Quebec, Canada" dated May 28, 2026 (with an effective date of January 17, 2026) (the "Technical Report"), in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects ("NI 43-101").

GlobeNewsWire • May 29, 2026

Osisko Metals Announces Results of Voting at 2026 Annual Meeting of Shareholders and Welcomes Keith McKay to the Board

TORONTO, May 28, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (TSX:OM "Osisko" or the "Corporation") announces the results of its annual meeting of shareholders (the "Meeting") held earlier today. A total of 475,369,374 common shares of the Corporation were represented at the Meeting, representing approximately 64.4% of the total number of common shares of the Corporation issued and outstanding.

GlobeNewsWire • May 28, 2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN JOSE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company's Inducement Plan, as a material inducement to employment to two newly appointed non-executive employees, in each case, who were not previous employees or directors of the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of any equity awards that are not made under a stockholder approved equity plan.

GlobeNewsWire • May 21, 2026

Outset Medical to Present at RBC Global Healthcare Conference

SAN JOSE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 19, 2026, at 10:30 a.m.

GlobeNewsWire • May 11, 2026

Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript

Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 9, 2026

Outset Medical Q1 Earnings Call Highlights

Outset Medical NASDAQ: OM reported first-quarter 2026 revenue of $27.9 million, as management pointed to “consistent execution” in console utilization, new customer additions, gross margin expansion, and cash discipline, while acknowledging that capital order timing weighed on results.

MarketBeat • May 8, 2026

Outset Medical Reports First-Quarter Results

SAN JOSE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the first quarter ended March 31, 2026.

GlobeNewsWire • May 7, 2026

Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to a loss of $3.24 per share a year ago.

Zacks Investment Research • May 7, 2026